University of California, Los Angeles
Los Angeles, California, 90095, United States
NCT Number: NCT04837573
The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.
Looking for future studies?
Notify Me40 year and older
Female
Interventional
Not applicable
Los Angeles, California, 90095, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is an 8-week, therapeutically-informed protocol.
Time frame: 12 weeks
Completion: # of participants who attended 4+ sessions/ # participants available to attend 4+ sessions Retention: # retained/ # enrolled
Time frame: 12 weeks
Qualitative assessment of Acceptability. The interview guide was organized according to the 7 constructs of the Theoretical Framework of Acceptability. Participants reported whether the intervention was an acceptable fit with their personal value of becoming more whole, and with their collective value of addressing their depressive symptoms and experiences in a trusted space.
Time frame: 6 weeks
Recruitment: # enrolled/# eligible
Time frame: Baseline to 6 weeks
Changes in psychological flexibility scores from baseline to 6 weeks using the Acceptance and Action Questionnaire II (AAQ-II). Scores range from 7-49. Lower scores indicate greater psychological flexibility (better outcome).
Kia Skrine Jeffers, PhD, RN, PHN
Other
Evaluating the Feasibility and Acceptability of a Therapeutically-Grounded Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05619510
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT04990401
Behavior, Behavioral Symptoms
Dallas, Texas, United States
View Trial DetailsNCT03517878
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Mqanduli, Eastern Cape, South Africa
View Trial DetailsNCT01696435
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial Details